| MR编号 | ES/V/0312/001 |
|---|
| 药品名称 | Cevac MD Rispens |
|---|
| 活性成分 | - Mareks Disease Virus 800.0 PFU
|
|---|
| 剂型 | Suspension and solvent for suspension for injection |
|---|
| 上市许可持有人 | Ceva-Phylaxia Veterinary Biologicals Co. Ltd. |
|---|
| 参考成员国 - 产品名称 | Spain (ES) CEVAC MD RISPENS |
|---|
| 互认成员国 - 产品名称 | - Hungary (HU)
- Bulgaria (BG)
- Cyprus (CY)
- Germany (DE)
- Czechia (CZ)
- Denmark (DK)
- Romania (RO)
- Belgium (BE)
- Slovakia (SK)
- Netherlands (NL)
- Slovenia (SI)
- Ireland (IE)
- Croatia (HR)
- Austria (AT)
- United Kingdom (Northern Ireland) (XI)
- France (FR)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
- Estonia (EE)
|
|---|
| 许可日期 | 2020/05/06 |
|---|
| 最近更新日期 | 2024/06/10 |
|---|
| 药物ATC编码 | - QI01AD03 avian herpes virus (marek's disease)
| 申请类型 | - TypeLevel1：food
- TypeLevel2：Immunological
- TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|